Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting, 77240-77241 [2011-31833]
Download as PDF
<![CDATA[
jlentini on DSK4TPTVN1PROD with NOTICES
77240
Federal Register / Vol. 76, No. 238 / Monday, December 12, 2011 / Notices
Date: January 20, 2012.
Open: 8:30 a.m. to 12:30 p.m.
Agenda: Presentation of NIMH Director’s
Report and discussion on NIMH program and
policy issues.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C/D/E,
Rockville, MD 20852.
Closed: 1:15 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C/D/E,
Rockville, MD 20852.
Contact Person: Jane A. Steinberg, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Mental Health, NIH,
Neuroscience Center, 6001 Executive Blvd.,
Room 6154, MSC 9609, Bethesda, MD 20892–
9609, (301) 443–5047.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
In the interest of security, visitors will be
asked to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://www.
nimh.nih.gov/about/advisory-boards-andgroups/namhc/index.shtml, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel,
Pain Assessment for Traumatic Brain Injury
Patients.
Date: January 11, 2012.
Time: 3:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Tamizchelvi Thyagarajan,
Ph.D., Scientific Review Officer, National
Institute of Nursing Research, National
Institutes of Health, Bethesda, MD 20892,
(301) 594–0343,
tamizchelvi.thyagarajan@nih.gov.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel,
Clinical Trial—Health Benefits Of Mother’s
Colostrum.
Date: January 18, 2012.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Tamizchelvi Thyagarajan,
Ph.D., Scientific Review Officer, National
Institute of Nursing Research, National
Institutes of Health, Bethesda, MD 20892,
(301) 594–0343,
tamizchelvi.thyagarajan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: December 6, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Dated: December 6, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–31839 Filed 12–9–11; 8:45 am]
[FR Doc. 2011–31837 Filed 12–9–11; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Mar<15>2010
15:55 Dec 09, 2011
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meetings
Office of Biotechnology Activities,
Office of Science Policy, Office of the
Director; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Science Advisory Board for
Biosecurity (NSABB).
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(b), Title 5 U.S.C. as amended.
Under authority 42 U.S.C. 217a, Section
222 of the Public Health Service Act, as
amended, the Department of Health and
Human Services established the NSABB
to provide advice, guidance and
leadership regarding federal oversight of
dual use research, defined as biological
research that generates information and
technologies that could be misused to
pose a biological threat to public health
and/or national security.
The meeting will be open to the
public via teleconference. Persons
planning to participate in this
teleconference should refer to the Callin Information listed on this notice. For
information about the open meeting
connect to: https://oba.od.nih.gov/
biosecurity/biosecurity_meetings.html.
Please check this site for updates.
Name of Committee: National Science
Advisory Board for Biosecurity.
Date: December 15, 2011.
Closed: December 15, 2011, 10 a.m. to
11:30 a.m.
Agenda: To review confidential
information.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, Maryland 20892,
(Telephone Conference Call).
Open: December 15, 2011, 12 p.m. to
1:30 p.m.
Agenda: Presentations and discussions
regarding: (1) Review of proposed NSABB
Codes of Conduct Working Group Draft
Report: ‘‘Enhancing Responsible Science
Considerations for the Development and
Dissemination of Codes of Conduct for Dual
Use Research;’’ (2) planning for future
NSABB meetings; and (3) other business of
the Board.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, Maryland 20892
(Telephone Conference Call).
Call-in Information: Toll-Free Number: 1–
(888) 989–9721 Participant Passcode:
7857009.
Contact Person: Ronna Hill, NSABB
Program Assistant, NIH Office of
Biotechnology Activities, 6705 Rockledge
Drive, Suite 750, Bethesda, Maryland 20892,
(301) 496–9838, hillro@od.nih.gov.
E:\FR\FM\12DEN1.SGM
12DEN1
Federal Register / Vol. 76, No. 238 / Monday, December 12, 2011 / Notices
This notice is being published less than 15
days before it is held because NIH was asked
by the Department of Health and Human
Services to convene the NSABB as soon as
possible due to the time-sensitive nature of
the matter for review.
Any member of the public interested in
presenting oral comments relevant to the
mission of the NSABB at the open meeting
should notify the Contact Person listed on
this notice. Interested individuals and
representatives of an organization may
submit a letter of intent, a brief description
of the organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments. Both
printed and electronic copies are requested
for the record. In addition, any interested
person may file written comments relevant to
the mission of the NSABB. All written
comments should be sent via email to the
Contact Person listed on this notice. The
written comments should include the name,
address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
Dated: December 6, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–31833 Filed 12–9–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jlentini on DSK4TPTVN1PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Advisory Allergy and Infectious
Diseases Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Mar<15>2010
15:55 Dec 09, 2011
Jkt 226001
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: January 30, 2012.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms E1/E2, Bethesda, MD
20892.
Closed: 11:40 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms E1/E2, Bethesda, MD
20892.
Contact Person: Mary Nuss, Committee
Management Officer, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7610,
Bethesda, MD 20892–7610, (301) 496–7601,
mnuss@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Allergy, Immunology and Transplantation
Subcommittee.
Date: January 30, 2012.
Open: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room D, Bethesda, MD 20892.
Closed: 1 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room D, Bethesda, MD 20892.
Contact Person: Mary Nuss, Committee
Management Officer, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7610,
Bethesda, MD 20892–7610, (301) 496–7601,
mnuss@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: January 30, 2012.
Open: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room A, Bethesda, MD 20892.
Closed: 1 p.m. to adjournment.
Agenda: Program advisory discussions and
reports from division staff.
Place: National Institutes of Health.
Natcher Building, 45 Center Drive,
Conference Rooms E1/E2, Bethesda, MD
20892.
Contact Person: Mary Nuss, Committee
Management Officer, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7610,
Bethesda, MD 20892–7610, (301) 496–7601,
mnuss@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Microbiology and Infectious Diseases
Subcommittee.
Date: January 30, 2012.
Open: 8:30 a.m. to 10:15 a.m.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
77241
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms F1/F2, Bethesda, MD
20892.
Closed: 1 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms F1/F2, Bethesda, MD
20892.
Contact Person: Mary Nuss, Committee
Management Officer, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7610,
Bethesda, MD 20892–7610, (301) 496–7601,
mnuss@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Microbiology and Infectious Diseases
Subcommittee.
Date: May 14, 2012.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms F1/F2, Bethesda, MD
20892.
Open: 1 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms F1/F2, Bethesda, MD
20892.
Contact Person: Mary Nuss, Committee
Management Officer, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7610,
Bethesda, MD 20892–7610, (301) 496–7601,
mnuss@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: May 14, 2012.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room A, Bethesda, MD 20892.
Open: 1 p.m. to adjournment.
Agenda: Program advisory discussions and
reports from division staff.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms E1/E2, Bethesda, MD
20892.
Contact Person: Mary Nuss, Committee
Management Officer, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700 Rockledge Drive, MSC 710,
Bethesda, MD 20892–7610, (301) 496–7601,
mnuss@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council,
Allergy, Immunology and Transplantation
Subcommittee.
Date: May 14, 2012.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\12DEN1.SGM
12DEN1
]]>Agencies
[Federal Register Volume 76, Number 238 (Monday, December 12, 2011)]
[Notices]
[Pages 77240-77241]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-31833]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of Biotechnology Activities, Office of Science Policy,
Office of the Director; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Science Advisory Board for Biosecurity (NSABB).
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(9)(b), Title 5 U.S.C. as
amended. Under authority 42 U.S.C. 217a, Section 222 of the Public
Health Service Act, as amended, the Department of Health and Human
Services established the NSABB to provide advice, guidance and
leadership regarding federal oversight of dual use research, defined as
biological research that generates information and technologies that
could be misused to pose a biological threat to public health and/or
national security.
The meeting will be open to the public via teleconference. Persons
planning to participate in this teleconference should refer to the
Call-in Information listed on this notice. For information about the
open meeting connect to: https://oba.od.nih.gov/biosecurity/biosecurity_meetings.html. Please check this site for updates.
Name of Committee: National Science Advisory Board for
Biosecurity.
Date: December 15, 2011.
Closed: December 15, 2011, 10 a.m. to 11:30 a.m.
Agenda: To review confidential information.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, Maryland 20892, (Telephone Conference Call).
Open: December 15, 2011, 12 p.m. to 1:30 p.m.
Agenda: Presentations and discussions regarding: (1) Review of
proposed NSABB Codes of Conduct Working Group Draft Report:
``Enhancing Responsible Science Considerations for the Development
and Dissemination of Codes of Conduct for Dual Use Research;'' (2)
planning for future NSABB meetings; and (3) other business of the
Board.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, Maryland 20892 (Telephone Conference Call).
Call-in Information: Toll-Free Number: 1-(888) 989-9721
Participant Passcode: 7857009.
Contact Person: Ronna Hill, NSABB Program Assistant, NIH Office
of Biotechnology Activities, 6705 Rockledge Drive, Suite 750,
Bethesda, Maryland 20892, (301) 496-9838, hillro@od.nih.gov.
[[Page 77241]]
This notice is being published less than 15 days before it is
held because NIH was asked by the Department of Health and Human
Services to convene the NSABB as soon as possible due to the time-
sensitive nature of the matter for review.
Any member of the public interested in presenting oral comments
relevant to the mission of the NSABB at the open meeting should
notify the Contact Person listed on this notice. Interested
individuals and representatives of an organization may submit a
letter of intent, a brief description of the organization
represented, and a short description of the oral presentation. Only
one representative of an organization may be allowed to present oral
comments. Both printed and electronic copies are requested for the
record. In addition, any interested person may file written comments
relevant to the mission of the NSABB. All written comments should be
sent via email to the Contact Person listed on this notice. The
written comments should include the name, address, telephone number
and, when applicable, the business or professional affiliation of
the interested person.
Dated: December 6, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-31833 Filed 12-9-11; 8:45 am]
BILLING CODE 4140-01-P
